Purple Innovation (PRPL) Tops Q1 EPS by 7c, Revenues Beat; Raises FY21 Revenues Mid-Point Guidance Above Consensus, 2Q Revs. View Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
Purple Innovation (PRPL) Prices 7.308M Shares Secondary Offering at $30/Sh
May 19, 2021 5:48 AM EDTPurple Innovation, Inc. (NASDAQ: PRPL), a leader in comfort innovation and the creator of the renowned Purple® Mattress, today announced the pricing of an underwritten secondary public offering of 7,308,792 shares of its Class A common stock to be sold by Coliseum Capital Partners, L.P., Coliseum Co-Invest Debt Fund, L.P., Blackwell Partners LLC Series A, and Coliseum Capital Co-Invest III, L.P. (collectively, the "Selling Stockholders"). The shares of Class A common stock are being sold at a price of... More
Purple Innovation (PRPL) Announces Proposed 7.309M Share Secondary Offering
May 18, 2021 4:37 PM EDTPurple Innovation, Inc. (NASDAQ: PRPL), a leader in comfort innovation and the creator of the renowned Purple® Mattress, today announced the launch of an underwritten secondary public offering of 7,308,792 shares of its Class A common stock to be sold by Coliseum Capital Partners, L.P., Coliseum Co-Invest Debt Fund, L.P., Blackwell Partners LLC Series A, and Coliseum Capital Co-Invest III, L.P. (collectively, the "Selling Stockholders"). The underwriters have a 30-day option period to purchase up to 1,096,318... More

